Skip to main content
Premium Trial:

Request an Annual Quote

ExonHit to Provide SpliceArray Content on Affymetrix GeneChip Platform

NEW YORK, Oct. 17 (GenomeWeb News) - ExonHit Therapeutics said today that it has inked a supply and service provider agreement to join its SpliceArray alternative RNA splicing technologies with Affymetrix's GeneChip microarray platform.


The first GeneChip arrays featuring ExonHit's technology are expected to be available on the Affymetrix platform by year end. These will include GPCR, ion channel, nuclear receptor, apoptosis, and the cytokine gene families, ExonHit said.


Customers will be able to access ExonHit's microarray content through a licensing agreement with the company. GeneChip arrays with the alternative RNA splicing technologies can then be purchased directly from Affymetrix.


"License fees will be directly proportional to the number of SpliceArrays purchased, with significant discounts for volume commitments and no reach-through rights," ExonHit said. "Alternatively, ExonHit ... can run and analyze customers' samples through its SpliceArray service."

Additional terms of the deal were not disclosed.


The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.